Your web browser is out of date.

For your security and improved experience online, please update your browser.

This site is intended for healthcare professionals only
×

Issue:

Early View

Share this article
Share on facebook
Share on twitter
Share on email
Share on print

CGM during pregnancy a cost-effective CONCEPTT

Devices – July 2019 digest

The NHS could save millions every year by offering continuous glucose monitoring to pregnant women with type 1 diabetes, according to cost-effectiveness data. 

The NHS could save millions every year by offering continuous glucose monitoring (CGM) to pregnant women with type 1 diabetes, according to cost-effectiveness data. 

The addition of real-time CGM to capillary blood glucose testing during pregnancy reduced the incidence of large-for-gestational-age babies, the number and length of neonatal intensive care admissions, and newborn hypoglycaemia in the CONCEPTT trial. When considering the mother, adding CGM to fingerprick testing increased the amount of time spent in the normal glycaemic range and reduced the length of hyperglycaemic periods. When all of the costs were taken into account, the use of CGM in pregnant women with type 1 diabetes was found to save about £2,500 per pregnancy and birth.

Adding CGM to routine therapy between weeks 10 and 38 of gestation would result in an estimated saving of £9,560,461 for NHS England based on an average of 1,441 pregnancies in women with type 1 diabetes each year. The main cost savings would be due to a significant reduction in neonate intensive care unit admissions and shorter durations of hospital stay.

For more ADA news, view the following:

Advertisement

Share this article
Share on facebook
Share on twitter
Share on linkedin
Share on email
Share on whatsapp
For the latest news and articles

Sign up to all DiabetesontheNet journals

© Copyright Omniamed Communications. All Rights Reserved​
108 Cannon Street, London, EC4N 6EU. Registered in the United Kingdom​
Omniamed logo white
For the latest news and articles

Sign up to all DiabetesontheNet journals

 

By clicking ‘Subscribe’, you are agreeing that DiabetesontheNet.com are able to email you periodic newsletters. You may unsubscribe from these at any time. Your info is safe with us and we will never sell or trade your details. For information please review our Privacy Policy.

DiabetesontheNet Logo

This website is for UK healthcare professionals only. To continue, please confirm that you are a UK healthcare professional below.